Novavax Terminates Influenza Vaccine Collaboration Negotiations With ROVI

Novavax has decided to terminate its negotiations with ROVI Pharmaceuticals, relating to previously announced collaboration. The collaboration was aimed at developing Novavax's virus-like-particle (VL...

Published: 08-Feb-2010

3SBio Seals Collaboration, License Agreement With Panacor Bioscience

3SBio has announced a collaboration and license agreement with Panacor Bioscience to develop and commercialize its Nephoxil pharmaceutical product, for the treatment of hyperphosphatemia in China. ...

Published: 08-Feb-2010

Health Decisions Completes Enrollment In Phase II Flu Vaccine Trial

Health Decisions, a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, has completed enrollment for a phase II universal flu vaccine study three week...

Published: 04-Feb-2010

Apeiron Licenses Enzyme Biotherapeutic Rights To GSK

Apeiron Biologics (Apeiron) has signed an agreement granting GlaxoSmithKline (GSK) exclusive rights to APN01 (recombinant human Angiotensin Converting Enzyme 2, rhACE2), an enzyme biotherapeutic curre...

Published: 03-Feb-2010

Evotec Collaborates With Vifor Pharma

Evotec has signed a cooperation agreement with Vifor Pharma, under which Evotec will provide and project manage the discovery activities to identify a preclinical candidate for the treatment of anaemi...

Published: 02-Feb-2010

Abbott Enters Into Cancer Research Collaboration With Pierre Fabre

Abbott has signed an exclusive worldwide licensing agreement with Pierre Fabre to develop and commercialize h224G11, a pre-clinical monoclonal antibody (identified at the Centre d'Immunologie Pierre F...

Published: 02-Feb-2010

Abbott Enters Into Cancer Research Collaboration With Pierre Fabre

Abbott has signed an exclusive worldwide licensing agreement with Pierre Fabre to develop and commercialize h224G11, a pre-clinical monoclonal antibody (identified at the Centre d'Immunologie Pierre F...

Published: 02-Feb-2010

TapImmune Enters Into R&D Collaboration With Aeras

TapImmune has signed a Letter of Intent (LoI) with Aeras Global TB Vaccine Foundation (Aeras) to enter into an R&D collaboration effort. The goal will be to evaluate the efficacy of TAP in concert wit...

Published: 01-Feb-2010

Spectrum Receives $16m From Collaboration Agreement For Apaziquone

Spectrum Pharmaceuticals has received $15m from Nippon Kayaku in connection with the collaboration agreement for apaziquone (EOquin) announced on November 10, 2009, and $1m from Handok Pharmaceuticals...

Published: 29-Jan-2010

Pacgen Forms R&D Collaboration With New Summit Biopharma

Pacgen Biopharmaceuticals (Pacgen) has entered into research and development agreements with New Summit Biopharma, to develop PAC-113 for the treatment of oral candidiasis for commercialization in Chi...

Published: 28-Jan-2010

more news...